Hormone Refractory Prostate Cancer Market by Key
Segments | Forecast Years:
2024-
2030
| CAGR:9.64%
{reportSlug=global-hormone-refractory-prostate-cancer-market, reportId=58694, mktKeyword=Hormone Refractory Prostate Cancer, cagr=9.64, publishDate=Mar 2024, priceOption2=6800, reportTitle=Hormone Refractory Prostate Cancer Comprehensive Study by Treatment (Chemotherapy, Hormonal Therapy, Immunotherapy, Radiation Therapy, Surgery), End-users (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), Diagnosis (CT Scan, MRI, PET, Ultrasound, Biopsy, Others) Players and Region - Global Market Outlook to 2030, baseYr=2023, totalTableFig=200, priceOption1=3650, forecastYr=2030, noOfPages=181, reportKey=58382, breadcrum=Global Hormone Refractory Prostate Cancer}
We do not share your information with anyone. However, we may send you
emails based on your report interest from time to time. You may contact
us at any time to opt-out.
Select User Access Type
Key Highlights of Report
Mar 2024
181 Pages
88 Tables
Base Year: 2023Coverage: 15+ Companies; 18
Countries